Jones Hill Capital is an equity long/short, low net hedge fund that specializes in the healthcare sector, with a particular focus on biotechnology and therapeutics. Led by its Chief Investment Officer, Soren Gandrud, the firm is rooted in catalyst-based, valuation-driven fundamental analysis, and guided by its mission to seek strong, consistent alpha and absolute returns, regardless of market conditions.